about
Monitoring changes in malaria epidemiology and effectiveness of interventions in Ethiopia and Uganda: Beyond Garki Project baseline surveyThe effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial.Effect of praziquantel treatment of Schistosoma mansoni during pregnancy on immune responses to schistosome antigens among the offspring: results of a randomised, placebo-controlled trial.Circulating B-lymphocytes as potential biomarkers of tuberculosis infection activity.Determining Mycobacterium tuberculosis infection among BCG-immunised Ugandan children by T-SPOT.TB and tuberculin skin testing.Impact of co-infections and BCG immunisation on immune responses among household contacts of tuberculosis patients in a Ugandan cohort.Long-lived memory B-cell responses following BCG vaccination.Factors affecting the infant antibody response to measles immunisation in Entebbe-UgandaEffect of maternal Schistosoma mansoni infection and praziquantel treatment during pregnancy on Schistosoma mansoni infection and immune responsiveness among offspring at age five years.Association between malaria exposure and Kaposi's sarcoma-associated herpes virus seropositivity in Uganda.Cellular immune activation in cerebrospinal fluid from ugandans with cryptococcal meningitis and immune reconstitution inflammatory syndrome.Investigating the non-specific effects of BCG vaccination on the innate immune system in Ugandan neonates: study protocol for a randomised controlled trial.Effect of isoniazid preventive therapy on immune responses to mycobacterium tuberculosis: an open label randomised, controlled, exploratory study.The Use of Interferon Gamma Inducible Protein 10 as a Potential Biomarker in the Diagnosis of Latent Tuberculosis Infection in Uganda.The impact of maternal infection with Mycobacterium tuberculosis on the infant response to bacille Calmette-Guérin immunization.Immunology in Africa.T-cell migration: a naive paradigm?Correspondence of Neutralizing Humoral Immunity and CD4 T Cell Responses in Long Recovered Sudan Virus SurvivorsMemory versus naive T-cell migration.Human eosinophils modulate peripheral blood mononuclear cell response to Schistosoma mansoni adult worm antigen in vitroHumoral Responses to Rv1733c, Rv0081, Rv1735c, and Rv1737c DosR Regulon-Encoded Proteins of Mycobacterium tuberculosis in Individuals with Latent Tuberculosis Infection.Maternal BCG scar is associated with increased infant proinflammatory immune responses.Marburg virus survivor immune responses are Th1 skewed with limited neutralizing antibody responses.Rethinking Schistosomiasis Vaccine Development: Synthetic Vesicles.The Yin and Yang of the Non-Specific Effects of Vaccines.Capacity for science in sub-Saharan Africa.Most B cells in non-lymphoid tissues are naïve.Diminished secondary CTL response in draining lymph nodes on cutaneous challenge with herpes simplex virus.CD4 T cells inhibit the CD8 T cell response during low-dose virus infection.Use of QuantiFERON®-TB Gold in-tube culture supernatants for measurement of antibody responses.Age of Infection with Kaposi Sarcoma Associated Herpesvirus and Subsequent Antibody Values Among Children in Uganda.Evidence that a significant number of naive T cells enter non-lymphoid organs as part of a normal migratory pathway.Monocyte Phenotype and IFN-γ-Inducible Cytokine Responses Are Associated with Cryptococcal Immune Reconstitution Inflammatory Syndrome.Effects of HIV infection and ART on phenotype and function of circulating monocytes, natural killer, and innate lymphoid cells.Relationship between Anaemia, Malaria Co-infection and Kaposi Sarcoma-associated Herpesvirus (KSHV) Seropositivity in a Population-based Study in Rural Uganda.Post-immunization leucocytosis and its implications for the management of febrile infants.Identification of conserved T cell receptor CDR3 residues contacting known exposed peptide side chains from a major histocompatibility complex class I-bound determinantExpression of two T cell receptor α chains on the surface of normal murine T cellsCharacterising antibody avidity in individuals of varied Mycobacterium tuberculosis infection status using surface plasmon resonanceLessons from the first clinical trial of a non-licensed vaccine among Ugandan adolescents: a phase II field trial of the tuberculosis candidate vaccine, MVA85A
P50
Q28608078-FA43D46D-737F-4332-B637-65F19912AC3DQ33637297-485BC229-81D4-48AA-9A6A-BAF4B86D53E7Q34010188-1CC8F7FD-B49C-4EC0-9E2A-A81DB0F0E09FQ34142550-AB8D66DE-2F16-40F3-91C5-9021535283BFQ34450737-57EAD5BD-2A36-4229-9BD1-04998713F39CQ34456369-160947B5-B43E-47DA-A073-DCE82AB2838AQ34512334-5877A9A5-ED14-437D-9D0B-AC24C4972B05Q34788596-D0D594C7-E863-4CE4-91BD-506428467FD9Q35023688-5177BFC1-FA09-40AF-A54B-F16627DA3815Q35328464-5AA5CFBE-B631-405E-BB6B-F761CDECF2BCQ35531947-CF50ECF5-4058-4098-83B2-C1DF49A68872Q35551354-8E0FE0A6-36CD-491F-A7A7-D835C9234D37Q35818084-1BCC87CC-B1C2-44F5-AAC2-B6F93A1B20B3Q35895230-E9590C27-FF95-492F-AB84-8FEA7839A36AQ35923817-6CAC4D68-C9A0-42A9-B836-4DA761DEEE6DQ36532554-DADF8D78-BEB1-40BA-ADA5-EB0F29A2C75DQ36711556-9737DB31-94DA-4523-A149-EE9B527B237FQ36947021-433C7383-A27E-4901-80C8-8AC84964DEB6Q36999676-4B8731D2-2F4F-440A-871A-35434A3326F2Q37152231-B87F0654-4D13-4DFD-9169-9EB87A700FAFQ37642329-466C4C6F-292D-4F35-93B0-4A5FCF588699Q37710283-0FF56513-0E98-425B-90C3-545F319DD427Q38848150-9F877A12-7BF1-4FA8-AA63-F34B18195C17Q38849208-3025CAEE-6591-4C47-B0F7-3845761A43B3Q38849267-58B16F4D-7703-48DE-BE46-BD5BF95EDD99Q38858637-1E6D8E38-7A9E-43B4-8D15-DDE05C25406EQ39545578-766BC8BC-0183-44E2-8086-5CE526CFC1C5Q40904342-47C6B036-B2D9-4262-816B-F24EEC83BB1AQ45415733-ABD51F16-4EA2-4EF0-B2F7-8E3DD5739D70Q46172607-181E9852-F34D-4E56-97EB-7A220EE5BD51Q47549010-DCFB810F-8DD9-4FA4-8226-A1B668A3E313Q48534206-6BCF77EE-714E-4ACD-8F21-80C3F6FD154FQ49679752-82362504-83A3-422A-961F-1A32FBFA50F7Q52653716-A230EED2-BD5E-4B43-A331-949AB2AE714EQ53684408-1D393D25-7FFB-453C-ADA8-1851395D57C3Q54235851-1F4DC87E-E0B3-483E-91D5-DE7A6FEC05A7Q57082205-C9CCBBA0-EB2C-4F67-B4B4-41DA05AB1B14Q57228132-21FBA983-E016-483C-8381-AEFC8D147817Q57472289-40CCB942-2E62-49A4-807D-1693F8F59503Q58643310-0A07BAD2-94EF-4C8F-A11F-40AFFCD4FEFA
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Stephen Cose
@ast
Stephen Cose
@en
Stephen Cose
@es
Stephen Cose
@nl
Stephen Cose
@sl
type
label
Stephen Cose
@ast
Stephen Cose
@en
Stephen Cose
@es
Stephen Cose
@nl
Stephen Cose
@sl
prefLabel
Stephen Cose
@ast
Stephen Cose
@en
Stephen Cose
@es
Stephen Cose
@nl
Stephen Cose
@sl
P106
P21
P31
P496
0000-0002-5156-037X